Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia
Open accessThe DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Background: Striatal dopamine (DA) synthesis capacity and release are elevated in schizophrenia (SCZ) and its putative prodrome, the clinical high risk (CHR) state. Striatal DA function results from the activity of midbrain DA neurons projecting mainly from the substantia nigra (SN). Elevated stress-induced DA release in SCZ and CHR was observed in the striatum; however, whether it is also elevated in the SN is unclear. The current study aims to determine whether nigral DA release in response to a validated stress task is altered in CHR and in antipsychotic-naïve SCZ. Further, we explore how DA release in the SN and striatum might be related. Methods: 24 CHR subjects, 9 antipsychotic-naïve SCZ and 25 healthy volunteers (HV) underwent 2 positron emission tomography (PET) scans using the DA D2/3 agonist radiotracer, [11C]-(+)-PHNO, which allows simultaneous investigations of DA in the SN and striatum. Psychosocial stress-induced DA release was estimated as the percentage differences in BPND (%[11C]-(+)-PHNO displacement) between stress and sensory-motor control sessions. Results: We observed a significant diagnostic group by session interaction, such that SCZ exhibited greater stress-induced [11C]-(+)-PHNO % displacement (25.90% ± 32.2%; mean ± SD), as compared to HVs (-10.94% ± 27.1%). Displacement in CHRs (-1.13% ± 32.2%) did not differ significantly from either HV or SCZ. Conclusion: Our findings suggest that elevated nigral DA responsiveness to stress is observed in antipsychotic-naïve SCZ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These techniques indicate that striatal dopamine synthesis, storage and release are elevated in patients with psychosis compared to healthy controls (HC) (45-48) with large effect sizes (49).”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tseng et al | 24 CHR | [ C]-1-PHNO | Stress-induced | | | |”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 2×
“aOther diagnoses includes: Major depression in remission (2), alcohol abuse (1).”
BackgroundMethodSimplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,021
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationHaber, S. N., Fudge, J. L., & McFarland, N. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02369.2000 · Cited by 1,610
City living and urban upbringing affect neural social stress processing in humans
Lederbogen, F., Kirsch, P., Haddad, L., Streit, F., Tost, H., Schuch, P., Wüst, S., Pruessner, J. C., Rietschel, M., Deuschle, M., et al. (2011) · Nature · doi:10.1038/nature10190 · Cited by 1,584
Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Fusar-Poli, P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1472 · Cited by 1,361
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,084
Miller, T. J., McGlashan, T. H., Rosen, J. L., Somjee, L., Markovich, P. J., Stein, K., & Woods, S. W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.863 · Cited by 873
Monitoring and Care of Young People at Incipient Risk of Psychosis
Yung, A. R., McGorry, P. D., McFarlane, C. A., Jackson, H. J., Patton, G. C., & Rakkar, A. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.283 · Cited by 772
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Dendritic release of dopamine in the substantia nigra
Cheramy, A., Leviel, V., & Glowinski, J. (1981) · Nature · doi:10.1038/289537a0 · Cited by 735
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Pruessner, J. C., Champagne, F., Meaney, M. J., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3422-03.2004 · Cited by 709
Haber, S. N., Kim, K.-S., Mailly, P., & Calzavara, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0271-06.2006 · Cited by 686
Joel, D., & Weiner, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00575-8 · Cited by 614
Dopaminergic Network Differences in Human Impulsivity
Buckholtz, J. W., Treadway, M. T., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Shelby, E. S., Smith, C. E., et al. (2010) · Science · doi:10.1126/science.1185778 · Cited by 600
Pruessner, J. C., Dedovic, K., Khalili-Mahani, N., Engert, V., Pruessner, M., Buss, C., Renwick, R., Dagher, A., Meaney, M. J., & Lupien, S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.041 · Cited by 593
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Substantia nigra/ventral tegmental reward prediction error disruption in psychosis
Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., & Fletcher, P. C. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002058 · Cited by 532
Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
Tziortzi, A. C., Searle, G. E., Tzimopoulou, S., Salinas, C., Beaver, J. D., Jenkinson, M., Laruelle, M., Rabiner, E. A., & Gunn, R. N. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.044 · Cited by 452
Gurevich, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 431
Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J. L., Narendran, R., Gil, R., Hackett, E., Girgis, R., Ojeil, N., Moore, H., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2414 · Cited by 398
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
Diaz, J., Lévesque, D., Lammers, C. H., Griffon, N., Martres, M.-P., Schwartz, J.-C., & Sokoloff, P. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00527-c · Cited by 352
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010160 · Cited by 343
Increased stress-induced dopamine release in psychosis
Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.009 · Cited by 277
Self-citationKoeltzow, T. E., Xu, M., Cooper, D. C., Hu, X.-T., Tonegawa, S., Wolf, M. E., & White, F. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02231.1998 · Cited by 234
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Alexoff, D., Logan, J., Jayne, M., Wong, C., & Tomasi, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411228111 · Cited by 230
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Bloomfield, M. A. P., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.027 · Cited by 215
Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198
Self-citationHowes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain · doi:10.1093/brain/awt264 · Cited by 198
Toru, M., Watanabe, S., Shibuya, H., Nishikawa, T., Noda, K., Mitsushio, H., Ichikawa, H., Kurumaji, A., Takashima, M., Mataga, N., et al. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06312.x · Cited by 191
Cragg, S. J., & Greenfield, S. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05738.1997 · Cited by 184
An automated method for the extraction of regional data from PET images
Rusjan, P., Mamo, D., Ginovart, N., Hussey, D., Vitcu, I., Yasuno, F., Tetsuya, S., Houle, S., & Kapur, S. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.01.011 · Cited by 177
Self-citationBoileau, I., Payer, D., Houle, S., Behzadi, A., Rusjan, P. M., Tong, J., Wilkins, D., Selby, P., George, T. P., Zack, M., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4371-11.2012 · Cited by 169
Self-citationThe dopaminergic basis of human behaviors: A review of molecular imaging studies
Egerton, A., Mehta, M. A., Montgomery, A. J., Lappin, J. M., Howes, O. D., Reeves, S. J., Cunningham, V. J., & Grasby, P. M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.005 · Cited by 159
Kumakura, Y., Cumming, P., Vernaleken, I., Buchholz, H.-G., Siessmeier, T., Heinz, A., Kienast, T., Bartenstein, P., & Gründer, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0805-07.2007 · Cited by 159
Shotbolt, P., Tziortzi, A. C., Searle, G. E., Colasanti, A., van der Aart, J., Abanades, S., Plisson, C., Miller, S. R., Huiban, M., Beaver, J. D., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.115 · Cited by 155
Tepper, J. M., Sun, B.-C., Martin, L. P., & Creese, I. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02519.1997 · Cited by 151
Akdeniz, C., Tost, H., Streit, F., Haddad, L., Wüst, S., Schäfer, A., Schneider, M., Rietschel, M., Kirsch, P., & Meyer-Lindenberg, A. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.35 · Cited by 151
Yoon, J. H., Minzenberg, M. J., Raouf, S., D’Esposito, M., & Carter, C. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.018 · Cited by 149
Ginovart, N., Galineau, L., Willeit, M., Mizrahi, R., Bloomfield, P. M., Seeman, P., Houle, S., Kapur, S., & Wilson, A. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03840.x · Cited by 146
Self-citationDeficits in striatal dopamine release in cannabis dependence
van de Giessen, E., Weinstein, J. J., Cassidy, C. M., Haney, M., Dong, Z., Ghazzaoui, R., Ojeil, N., Kegeles, L. S., Xu, X., Vadhan, N. P., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.21 · Cited by 138
Kessler, R. M., Woodward, N. D., Riccardi, P., Li, R., Ansari, M. S., Anderson, S., Dawant, B., Zald, D., & Meltzer, H. Y. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.029 · Cited by 136
Kambeitz, J., Abi-Dargham, A., Kapur, S., & Howes, O. D. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.132308 · Cited by 115
Willeit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107
Self-citationMueller, H. T., Haroutunian, V. H., Davis, K. L., & Meador‐Woodruff, J. H. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.004 · Cited by 102
Mizrahi, R., Kenk, M., Suridjan, I., Boileau, I., George, T. P., McKenzie, K., Wilson, A. A., Houle, S., & Rusjan, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.347 · Cited by 101
Self-citationPositron Emission Tomography Quantification of [11C]-(+)-PHNO Binding in the Human Brain
Ginovart, N., Willeit, M., Rusjan, P., Graff, A., Bloomfield, P. M., Houle, S., Kapur, S., & Wilson, A. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600411 · Cited by 96
Self-citationDifferential expression of autoreceptors in the ascending dopamine systems of the human brain.
Meador-Woodruff, J. H., Damask, S. P., & Watson, S. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8297 · Cited by 84
Gallezot, J., Beaver, J. D., Gunn, R. N., Nabulsi, N., Weinzimmer, D., Singhal, T., Slifstein, M., Fowles, K., Ding, Y., Huang, Y., et al. (2012) · Synapse · doi:10.1002/syn.21535 · Cited by 84
Pérez‐Costas, E., Meléndez‐Ferro, M., Rice, M. W., Conley, R. R., & Roberts, R. C. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00031 · Cited by 58
Rivet, J., Audinot, V., Gobert, A., Péglion, J.-L., & Millan, M. J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90429-4 · Cited by 58
Dopamine D3 receptor antisense influences dopamine synthesis in rat brain
IMissbrandt, H., Ekman, A., Eriksson, E., & Heilig, M. (1995) · NeuroReport · doi:10.1097/00001756-199502000-00041 · Cited by 56
Gallezot, J.-D., Zheng, M.-Q., Lim, K., Lin, S.-F., Labaree, D., Matuskey, D., Huang, Y., Ding, Y.-S., Carson, R. E., & Malison, R. T. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132928 · Cited by 55
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
Mizrahi, R., Suridjan, I., Kenk, M., George, T. P., Wilson, A. A., Houle, S., & Rusjan, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.232 · Cited by 51
Self-citationMapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia
Rice, M. W., Roberts, R. C., Meléndez‐Ferro, M., & Pérez‐Costas, E. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0901-y · Cited by 47
Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers
Booij, L., Welfeld, K., Leyton, M., Dagher, A., Boileau, I., Sibon, I., Baker, G. B., Diksic, M., Soucy, J.-P., Pruessner, J. C., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.6 · Cited by 47
Suridjan, I., Rusjan, P., Addington, J., Wilson, A. A., Houle, S., & Mizrahi, R. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110181 · Cited by 38
Self-citationSuridjan, I., Boileau, I., Bagby, M. R., Rusjan, P., Wilson, A. A., Houle, S., & Mizrahi, R. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.009 · Cited by 36
Self-citationDopamine D2 receptors in substantia nigra in schizophrenia
Owen, R., Owen, F., Poulter, M., & Crow, T. J. (1984) · Brain Research · doi:10.1016/0006-8993(84)90798-4 · Cited by 29
Yoon, J. H., Westphal, A. J., Minzenberg, M. J., Niendam, T., Ragland, J. D., Lesh, T., Solomon, M., & Carter, C. S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.022 · Cited by 28
No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder
Hernaus, D., Collip, D., Kasanova, Z., Winz, O., Heinzel, A., van Amelsvoort, T., Shali, S. M., Booij, J., Rong, Y., Piel, M., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.37 · Cited by 23
Lee, D. E., Gallezot, J., Zheng, M., Lim, K., Ding, Y., Huang, Y. H., Carson, R. E., Morris, E. D., & Cosgrove, K. (2013) · PubMed · doi:10.2310/7290.2012.00025 · Cited by 15
Research works printed but not linked: 1
- 61. Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C] raclopride. J Neurosci. 2004;24:2825–2831. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Martel, J. C., & Gatti McArthur, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01003 · Cited by 229
Howes, O. D., Hird, E. J., Adams, R. A., Corlett, P. R., & McGuire, P. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.012 · Cited by 110
Salivary microbiome profiling reveals a dysbiotic schizophrenia-associated microbiota
Qing, Y., Xu, L., Cui, G., Sun, L., Hu, X., Yang, X., Jiang, J., Zhang, J., Zhang, T., Wang, T., et al. (2021) · Schizophrenia · doi:10.1038/s41537-021-00180-1 · Cited by 55
Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity
Vinogradov, S., Chafee, M. V., Lee, E. G., & Morishita, H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01451-w · Cited by 55
Metadata
- Authors
- Tseng, H.-H., Watts, J. J., Kiang, M., Suridjan, I., Wilson, A. A., Houle, S., Rusjan, P. M., & Mizrahi, R.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada
- Corresponding author
- Mizrahi, Romina
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06-13
- Volume
- 44
- Issue
- 3
- Pages
- 542-551
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC5890468
- OpenAlex
- W2603264399
- Cited by
- 31
- References
- 66
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 2
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Schizophrenia Bulletin (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ontario Mental Health Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- schizophrenia
- MeSH terms
- Adult, Corpus Striatum, Dopamine, Female, Humans, Male, Oxazines, Risk, Schizophrenia, Stress, Psychological, Substantia Nigra, Dopamine Agonists, Radiopharmaceuticals, Positron-Emission Tomography, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.